New first-line therapy for HER2-positive metastatic breast cancer shows promising results in clinical trial data.

Valneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553 ...

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

The investment will support the production of a drug linker for a commercial antibody-drug conjugate (ADC), enabling CARBOGEN AMCIS to meet rising global demand. As part of the agreement, both ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and ...

By Priya Kalia, SciTribe and Miranda Weston-Smith, BioBeat.

Accuray Incorporated  today announced that, after an extensive review over the last several months, including the evaluation of numerous potential financing partners, it has entered into privately ...

Conagra Brands, Inc. announced that it has entered into a definitive agreement with High Liner Foods to sell its Van de Kamp's® and Mrs. Paul's® frozen seafood brands for $55 million in cash. The ...

Under Trump, the U.S. will no longer recommended Covid shots for healthy pregnant women. Does the evidence support that ...

Because pregnancy suppresses the immune system, pregnant people are more likely to get sick and have a harder time fighting ...